Social and structural factors associated with HIV disease progression among illicit drug users
PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia
Overall benefit of antiretroviral treatment on the risk of fracture in HIV
Genotype assays and third-line ART in resource-limited settings
When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis
The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease
Extensive and complex HIV-1 recombination between B’, C and CRF01_AE among IDUs in south-east Asia
Comparing different measures of retention in outpatient HIV care
Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection
Safety of tenofovir use during pregnancy
Impact of malnutrition and social determinants on survival of HIV-infected adults starting antiretroviral therapy in resource-limited settings
Does maternal use of tenofovir during pregnancy affect growth of HIV-exposed uninfected infants?
Political lessons from the global HIV/AIDS response to inform a rapid noncommunicable disease response
Protecting the public's health
B-cell activation induced microRNA-21 is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas
Baseline E138 reverse transcriptase resistance-associated mutations in antiretroviral-naive HIV-infected patients
Toll-like receptor-2 ligand lipomannan from Mycobacterium tuberculosis does not stimulate inflammatory cytokines in dendritic cells
Reply to ‘TLR-2 ligand lipomannan from Mycobacterium tuberculosis does not stimulate inflammatory cytokines in dendritic cells’